Search Results

There are 2217 results for: content related to: The JAK2 V617F mutation and thrombosis

  1. You have free access to this content
    JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation

    British Journal of Haematology

    Volume 150, Issue 3, August 2010, Pages: 334–344, Seido Oku, Katsuto Takenaka, Takuro Kuriyama, Kotaro Shide, Takashi Kumano, Yoshikane Kikushige, Shingo Urata, Takuji Yamauchi, Chika Iwamoto, Haruko K. Shimoda, Toshihiro Miyamoto, Koji Nagafuji, Junji Kishimoto, Kazuya Shimoda and Koichi Akashi

    Article first published online : 10 JUN 2010, DOI: 10.1111/j.1365-2141.2010.08249.x

  2. You have free access to this content
    JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events

    American Journal of Hematology

    Volume 89, Issue 5, May 2014, Pages: 517–523, Alberto Alvarez-Larrán, Beatriz Bellosillo, Arturo Pereira, Ana Kerguelen, Juan Carlos Hernández-Boluda, Luz Martínez-Avilés, Concepción Fernández-Rodríguez, Montse Gómez, Luis Lombardía, Anna Angona, Águeda Ancochea, Alicia Senín, Raquel Longarón, Blanca Navarro, María Collado and Carlos Besses

    Article first published online : 21 FEB 2014, DOI: 10.1002/ajh.23676

  3. The role of serum erythropoietin level and jak2 v617f allele burden in the diagnosis of polycythaemia vera

    British Journal of Haematology

    Volume 167, Issue 3, November 2014, Pages: 411–417, Àgueda Ancochea, Alberto Álvarez-Larrán, Cristian Morales-Indiano, Francesc García-Pallarols, Luz Martínez-Avilés, Anna Angona, Alicia Senín, Beatriz Bellosillo and Carles Besses

    Article first published online : 18 JUL 2014, DOI: 10.1111/bjh.13047

  4. You have free access to this content
    Molecular diagnostics of myeloproliferative neoplasms

    European Journal of Haematology

    Stephen E. Langabeer, Hajnalka Andrikovics, Julia Asp, Beatriz Bellosillo, Serge Carillo, Karl Haslam, Lasse Kjaer, Eric Lippert, Olivier Mansier, Elisabeth Oppliger Leibundgut, Melanie J. Percy, Naomi Porret, Lars Palmqvist, Jiri Schwarz, Mary F. McMullin, Susanne Schnittger, Niels Pallisgaard, Sylvie Hermouet and on behalf of the MPN&MPNr-EuroNet

    Article first published online : 18 MAY 2015, DOI: 10.1111/ejh.12578

  5. You have free access to this content
    Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations

    British Journal of Haematology

    Volume 160, Issue 1, January 2013, Pages: 25–34, Anthony J. Bench, Helen E. White, Letizia Foroni, Anna L. Godfrey, Gareth Gerrard, Susanna Akiki, Abida Awan, Ian Carter, Andrea Goday-Fernandez, Stephen E. Langabeer, Tim Clench, Jordan Clark, Paul A. Evans, David Grimwade, Anna Schuh, Mary F. McMullin, Anthony R. Green, Claire N. Harrison and Nicholas C. P. Cross

    Article first published online : 11 OCT 2012, DOI: 10.1111/bjh.12075

  6. You have free access to this content
    The JAK2 V617F mutation in patients with cerebral venous thrombosis

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 6, June 2012, Pages: 998–1003, S. M. PASSAMONTI, E. BIGUZZI, M. CAZZOLA, F. FRANCHI, F. GIANNIELLO, P. BUCCIARELLI, D. PIETRA, P. M. MANNUCCI and I. MARTINELLI

    Article first published online : 31 MAY 2012, DOI: 10.1111/j.1538-7836.2012.04719.x

  7. JAK2 46/1 haplotype is associated with JAK2 V617F – positive myeloproliferative neoplasms in Brazilian patients

    International Journal of Laboratory Hematology

    L. C. Macedo, B. C. Santos, S. Pagliarini-e-Silva, K. B. B. Pagnano, C. Rodrigues, F. C. Quintero, M. E. Ferreira, E. C. Baraldi, E. P. Ambrosio-Albuquerque, A. M. Sell and J. E. L. Visentainer

    Article first published online : 11 MAY 2015, DOI: 10.1111/ijlh.12380

  8. You have free access to this content
    Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease

    American Journal of Hematology

    Volume 90, Issue 1, January 2015, Pages: E17–E21, Axel Muendlein, Elena Kinz, Klaus Gasser, Andreas Leiherer, Philipp Rein, Christoph H. Saely, Harald Grallert, Annette Peters, Peter Fraunberger, Heinz Drexel and Alois H. Lang

    Article first published online : 20 NOV 2014, DOI: 10.1002/ajh.23874

  9. You have free access to this content
    Experimental therapeutics for patients with myeloproliferative neoplasias

    Cancer

    Volume 117, Issue 4, 15 February 2011, Pages: 662–676, Meetu Agrawal, Ravin J. Garg, Jorge Cortes, Hagop Kantarjian, Srdan Verstovsek and Alfonso Quintas-Cardama

    Article first published online : 4 OCT 2010, DOI: 10.1002/cncr.25672

  10. You have full text access to this Open Access content
    Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1

    Journal of Cellular and Molecular Medicine

    Volume 13, Issue 2, February 2009, Pages: 215–237, Ayalew Tefferi

    Article first published online : 23 OCT 2008, DOI: 10.1111/j.1582-4934.2008.00559.x

  11. You have free access to this content
    Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms

    British Journal of Haematology

    Volume 147, Issue 4, November 2009, Pages: 495–506, Lizz F. Grimwade, Lisa Happerfield, Colin Tristram, Gary McIntosh, Mark Rees, Anthony J. Bench, Elaine M. Boyd, Marie Hall, Amy Quinn, Nigel Piggott, Paul Scorer, Mike A. Scott and Wendy N. Erber

    Article first published online : 31 AUG 2009, DOI: 10.1111/j.1365-2141.2009.07870.x

  12. You have free access to this content
    Evaluation of the prevalence and prospective clinical impact of the JAK2 V617F mutation in coronary patients

    American Journal of Hematology

    Volume 89, Issue 3, March 2014, Pages: 295–301, Axel Muendlein, Klaus Gasser, Elena Kinz, Nicole Stark, Andreas Leiherer, Philipp Rein, Christoph H. Saely, Harald Grallert, Annette Peters, Heinz Drexel and Alois H. Lang

    Article first published online : 18 FEB 2014, DOI: 10.1002/ajh.23632

  13. Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera

    European Journal of Haematology

    Volume 94, Issue 3, March 2015, Pages: 251–257, Anna Angona, Alberto Alvarez-Larrán, Beatriz Bellosillo, Luz Martínez-Avilés, Laura Camacho, Concepción Fernández-Rodríguez, Silvia Pairet, Raquel Longarón, Águeda Ancochea, Alicia Senín, Lourdes Florensa and Carles Besses

    Article first published online : 13 SEP 2014, DOI: 10.1111/ejh.12425

  14. You have free access to this content
    Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population

    British Journal of Haematology

    Volume 160, Issue 1, January 2013, Pages: 70–79, Camilla Nielsen, Henrik S. Birgens, Børge G. Nordestgaard and Stig E. Bojesen

    Article first published online : 1 NOV 2012, DOI: 10.1111/bjh.12099

  15. You have free access to this content
    Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients

    British Journal of Haematology

    Volume 152, Issue 4, February 2011, Pages: 413–419, Carlos Besses, Alberto Álvarez-Larrán, Luz Martínez-Avilés, Sergi Mojal, Raquel Longarón, Antonio Salar, Lourdes Florensa, Sergi Serrano and Beatriz Bellosillo

    Article first published online : 10 JAN 2011, DOI: 10.1111/j.1365-2141.2010.08467.x

  16. You have free access to this content
    Splanchnic vein thrombosis in myeloproliferative neoplasms

    British Journal of Haematology

    Volume 162, Issue 6, September 2013, Pages: 730–747, Mallika Sekhar, Kathryn McVinnie and Andrew K. Burroughs

    Article first published online : 15 JUL 2013, DOI: 10.1111/bjh.12461

  17. You have free access to this content
    Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders

    Journal of Thrombosis and Haemostasis

    Volume 5, Issue 4, April 2007, Pages: 708–714, V. DE STEFANO, A. FIORINI, E. ROSSI, T. ZA, G. FARINA, P. CHIUSOLO, S. SICA and G. LEONE

    Article first published online : 29 JAN 2007, DOI: 10.1111/j.1538-7836.2007.02424.x

  18. You have free access to this content
    Clinical correlates of JAK2V617F allele burden in essential thrombocythemia

    Cancer

    Volume 109, Issue 11, 1 June 2007, Pages: 2279–2284, Jaya Kittur, Ryan A. Knudson, Terra L. Lasho, Christy M. Finke, Naseema Gangat, Alexandra P. Wolanskyj, Chin-Yang Li, Wenting Wu, Rhett P. Ketterling, Animesh Pardanani and Ayalew Tefferi

    Article first published online : 17 APR 2007, DOI: 10.1002/cncr.22663

  19. You have free access to this content
    The JAK2V617F tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

    British Journal of Haematology

    Volume 131, Issue 3, November 2005, Pages: 320–328, Ayalew Tefferi, Terra L. Lasho, Susan M. Schwager, David P. Steensma, Ruben A. Mesa, Chin-Yang Li, Martha Wadleigh and D. Gary Gilliland

    Article first published online : 26 SEP 2005, DOI: 10.1111/j.1365-2141.2005.05776.x

  20. Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia

    Pediatric Blood & Cancer

    Volume 51, Issue 6, December 2008, Pages: 802–805, Takuya Nakatani, Toshihiko Imamura, Hiroyuki Ishida, Katsuji Wakaizumi, Tohru Yamamoto, Osamu Otabe, Tsuyoshi Ishigami, Souichi Adachi and Akira Morimoto

    Article first published online : 18 SEP 2008, DOI: 10.1002/pbc.21730